CML
Selected indexed studies
- Management of CML and Pregnancy in Low-and Middle-income Countries. (Indian J Hematol Blood Transfus, 2025) [PMID:39917486]
- Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature Review. (J Blood Med, 2023) [PMID:37051025]
- Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection. (Biomicrofluidics, 2024) [PMID:38283720]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Management of CML and Pregnancy in Low-and Middle-income Countries. (2025) pubmed
- Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature Review. (2023) pubmed
- Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection. (2024) pubmed
- Update on CML-Like Disorders. (2020) pubmed
- Accelerated-phase CML: de novo and transformed. (2023) pubmed
- Differences between normal and CML stem cells: potential targets for clinical exploitation. (1998) pubmed
- Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. (1991) pubmed
- Tailored tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) based on current evidence. (2021) pubmed
- Olverembatinib: First Approval. (2022) pubmed
- A Systematic Review on Second Treatment-Free Remission (TFR) Attempt in Chronic Myeloid Leukemia (CML): Can it be Applied in Clinical Practice? (2023) pubmed